Cedric Gunaratnam

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

An update on targeting airway inflammation in cystic fibrosis.

An update on targeting airway inflammation in cystic fibrosis.

Journal: Expert review of respiratory medicine

Published: June 12, 2025

CFTR modulator therapy impacts neutrophil CD39 expression in cystic fibrosis.

CFTR modulator therapy impacts neutrophil CD39 expression in cystic fibrosis.

Journal: American journal of respiratory cell and molecular biology

Published: May 01, 2025

Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.

Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.

Journal: Thorax

Published: April 16, 2024

Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency.

Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: September 07, 2023

Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.

Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.

Journal: American journal of respiratory and critical care medicine

Published: August 25, 2023

Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.

Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.

Journal: Thorax

Published: December 15, 2022

Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency.

Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: April 11, 2022

Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis.

Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: January 12, 2022

Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis.

Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis.

Journal: Frontiers in immunology

Published: August 28, 2020

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 22, 2020

An integrated multidisciplinary model of COVID-19 recovery care.

An integrated multidisciplinary model of COVID-19 recovery care.

Journal: Irish journal of medical science

Published: July 14, 2020

Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).

Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).

Journal: Thorax

Published: July 02, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026